Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades8
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020
27 Aug 2019 - Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development
5 Aug 2019 - WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks
12 Jul 2019 - Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity
12 Jul 2019 - Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use
26 Jun 2019 - Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial
14 Jun 2019 - Faron Pharmaceuticals reports 'significant' findings from YODA study
14 Jun 2019 - Faron Pharma Finance Head Wichmann Steps Down, Hanninen Replaces
24 May 2019
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020
(Alliance News) - Faron Pharmaceuticals Oy on Tuesday said it has raised EUR2.5 million via share subscription and open offer.The company raised EUR1....
Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development
(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical develo...
WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS-------...
Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity
(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand t...
Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use
(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is l...
Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial
(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as...
Faron Pharmaceuticals reports 'significant' findings from YODA study
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced results from its pharmacokinetic/dynamic 'YODA' study exam...
Faron Pharma Finance Head Wichmann Steps Down, Hanninen Replaces
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Friday said it has made several managerial changes, which it believes will strengthen its operati...
Follow the stocks
